New Zealand markets closed

Golden Sun Health Technology Group Limited (GSUN)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.9300+0.4000 (+15.81%)
At close: 04:00PM EDT
3.0700 +0.14 (+4.78%)
After hours: 07:54PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 5.59M
Enterprise value 3.83M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.89
Price/book (mrq)1.26
Enterprise value/revenue 0.62
Enterprise value/EBITDA -0.79

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-79.89%
S&P500 52-week change 322.38%
52-week high 313.0000
52-week low 32.2100
50-day moving average 35.0475
200-day moving average 36.6520

Share statistics

Avg vol (3-month) 315.95k
Avg vol (10-day) 334k
Shares outstanding 51.51M
Implied shares outstanding 61.91M
Float 81.19M
% held by insiders 120.86%
% held by institutions 10.10%
Shares short (15 Apr 2024) 423.67k
Short ratio (15 Apr 2024) 44.64
Short % of float (15 Apr 2024) 42.41%
Short % of shares outstanding (15 Apr 2024) 41.24%
Shares short (prior month 15 Mar 2024) 418.41k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 319 Apr 2024

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2023
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin -94.00%
Operating margin (ttm)-78.97%

Management effectiveness

Return on assets (ttm)-17.89%
Return on equity (ttm)-88.18%

Income statement

Revenue (ttm)6.16M
Revenue per share (ttm)3.27
Quarterly revenue growth (yoy)-27.20%
Gross profit (ttm)N/A
EBITDA -5.98M
Net income avi to common (ttm)-5.79M
Diluted EPS (ttm)-3.1000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)6.55M
Total cash per share (mrq)3.43
Total debt (mrq)4.86M
Total debt/equity (mrq)110.97%
Current ratio (mrq)1.11
Book value per share (mrq)2.32

Cash flow statement

Operating cash flow (ttm)-7.94M
Levered free cash flow (ttm)-6.88M